Dallas, Texas 75390

  • Afebrile

Purpose:

This is a single center, prospective, non-randomized prospective observational data collection study of the Verily Patch. The Verily Patch is an investigational wearable, continuous temperature sensor which will be evaluated against reference oral and axillary temperature measurements to support development activities for the Verily Patch.


Criteria:

Inclusion Criteria: - At least 18 years old - Able to read and speak English - Able to read and understand the Informed Consent Form - Willing to wear Verily Patch in the axillary region - Willing to comply with repeated self-measurement of oral and axillary temperatures and willing to record temperature readings - Have a working smartphone device and willing to use it for study activities - Willing to install study apps on their personal smartphone - Willing to comply with all study-related procedures Exclusion Criteria: - Pregnant or breastfeeding during study participation - Have known allergies to medical grade adhesives - Have known cutaneous hypersensitivity - Have infection in both axilla - Have open injury or rash where the study device will be worn - Have a cardiac pacemaker or other implanted electronic medical device(s) - Have any additional condition or situation that, in the opinion of the investigator, makes the subject inappropriate for participation in the study


NCT ID:

NCT04727801


Primary Contact:

Study Director
William Marks, MD
Verily Life Sciences

Bridget Hurley
Phone: 650-253-0000
Email: bahurley@verily.com


Backup Contact:

N/A


Location Contact:

Dallas, Texas 75390
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: June 22, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.